SCHEMBL8852192

SCHEMBL8852192

Cc1ccccc1S(=O)(=O)NC(C)C(C)[NH]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.50
SLC1A2 P43004 1/20 0.50
SLC1A1 P43005 1/20 0.50
ALDH1A1 P00352 3/20 0.46
LMNA P02545 3/20 0.46
POLB P06746 2/20 0.46
KMT2A Q03164 2/20 0.46
HTT P42858 2/20 0.46
MAPT P10636 1/20 0.46
ITGAV P06756 2/20 0.45
TDP1 Q9NUW8 2/20 0.42
TP53 P04637 1/20 0.42
EDNRA P25101 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.40
PKM P14618 2/20 0.39
KAT6A Q92794 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.39
EDNRB P24530 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851832 0.87 SLC1A3 (0.54) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL20478178 0.86 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL9001208 0.82 SLC1A3 (0.55) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL8851519 0.78 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL8851493 0.78 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL23518183 0.75 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL27895996 0.75 SLC1A3 (0.64) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL14798294 0.75 SLC1A3 (0.64) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL10765699 0.75 SLC1A3 (0.64) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA
SCHEMBL10530500 0.74 ALDH1A1 (0.49) SLC1A3SLC1A2SLC1A1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed